To build successful life sciences startups while helping catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem in Houston.
WHY AND HOW?
Houston receives over $1B in basic research funding a year, yet commercialization of life science technologies lags. This is true more broadly of federally-funded academic research across the U.S. and even de-prioritized industry R&D.
> We collaborate with academic researchers and innovators to de-risk the science and advance technologies through clinical proof of concept. Our management team and network includes veteran life science leaders who previously led successful clinical Phase 3 drug development and clinical trials, business development, investors, I.P and legal counsel, and regulatory advisors.
The Texas Medical Center is home to over 8,000 early-career scientists and engineers, but lacks the critical mass of early-stage life-science entrepreneurs who can develop technologies and attract investment.
> We grow entrepreneurs through our internship and fellowship programs, that provide experiential learning and training to young scientists and engineers—over 140 in the last five years.
• A for-profit, early-stage, life sciences development group.
• We bridge the gap between academic research and clinical proof of concept.
• … A Studio!
WE ARE NOT…
• Investors (in non-Fannin startups).
• A traditional accelerator/incubator.
• An economic development group.
HOW IT WORKS
• We in-license assets or technologies and develop them internally.
• We drive early R&D through clinical proof of concept.
• We partner or spin-out an asset when ready.
NON-DILUTIVE AND INVESTOR CAPITAL
We work with our academic collaborators to seek grants and other non-dilutive funding to de-risk early science and technology, while accessing traditional capital when appropriate.
Our experienced team collectively manages our pipeline of assets and technologies until a stand-alone management team is required.
EARLY PROJECT FUNDING
We allocate seed-stage capital to in-licensed assets or projects to support third-party expenses such as I.P. costs or independent replication of key experiments.
INFRASTRUCTURE AND RESOURCES
Our space and back-office support is efficiently shared across our portfolio, as is our network of industry partners and service providers.